The transfusion management of beta thalassemia in the United States
Transfusion
.
2021 Oct;61(10):3027-3039.
doi: 10.1111/trf.16640.
Epub 2021 Aug 28.
Authors
Ashutosh Lal
1
,
Trisha Wong
2
,
Siobán Keel
3
,
Monica Pagano
3
4
,
Jong Chung
5
,
Aditi Kamdar
6
,
Latha Rao
7
,
Alan Ikeda
8
,
Geetha Puthenveetil
9
,
Sanjay Shah
10
,
Jennifer Yu
11
,
Elliott Vichinsky
1
Affiliations
1
Pediatric Hematology, University of California, San Francisco, California, USA.
2
Pediatric Hematology/Oncology, Oregon Health and Science University, Portland, Oregon, USA.
3
Division of Hematology, University of Washington School of Medicine, Seattle, Washington, USA.
4
Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
5
Pediatric Hematology/Oncology, University of California, Davis, California, USA.
6
Pediatric Hematology/Oncology, Stanford University, Stanford, California, USA.
7
Pediatric Hematology/Oncology, Valley Children's Hospital, Madera, California, USA.
8
Pediatric Hematology/Oncology, Children's Specialty Center of Nevada, Las Vegas, Nevada, USA.
9
Pediatric Hematology/Oncology, Children's Hospital of Orange County, Orange, California, USA.
10
Pediatric Hematology/Oncology, Phoenix Children's Hospital, Phoenix, Arizona, USA.
11
Pediatric Hematology/Oncology, Rady Children's Hospital, San Diego, California, USA.
PMID:
34453453
PMCID:
PMC9292563
DOI:
10.1111/trf.16640
No abstract available
Publication types
Research Support, U.S. Gov't, P.H.S.
Review
MeSH terms
Blood Transfusion* / methods
Disease Management
Humans
United States / epidemiology
beta-Thalassemia / epidemiology
beta-Thalassemia / therapy*